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Abstract
An array of examples of diastereoselective, phosphate tether-mediated ring-closing metathesis
reactions, which highlight the importance of product ring size and substrate stereochemical
compatibility, as well as complexity, is reported. Studies focus primarily on the formation of
bicyclo[n.3.1]phosphates, involving the coupling of C2-symmetric dienediol subunits with a
variety of simple, as well as complex alcohol cross-partners.
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Introduction
The development of atom-,[1] step-,[2] and redox-economical[3] methods to generate
important subunits common to a variety of biologically-relevant natural products stands at
the forefront of modern-day synthesis and drug discovery. In particular, tether-mediated
methodologies which couple both simple and complex molecular fragments to access highly
functionalized core intermediates represent some of the most facile and convergent
pathways to accomplish this goal.[4] Over the past decade, we have investigated the use of
phosphate tethers to access complex polyol fragments via the desymmetrization of 1,3-anti-
diol subunits using ring-closing metathesis (RCM) and one-pot, sequential RCM/CM/
hydrogenation protocols.[5] In this regard, reported studies have focused solely on the use of
simple allyl alcohol coupling partners to synthesize bicyclo[4.3.1]-phosphates en route to the
syntheses of bioactive natural products.[6] Despite obvious attributes, a thorough
understanding of the behavior of phosphate tethers across a wide range of substrates
represents a notable deficiency that impedes general applicability of the method—as well as
extensive use—in the synthesis of biologically active small molecules. This stands in
contrast to seminal works by Evans, Kobayashi, and others that have provided insight on the
behavior of silicon tethers to RCM in a variety of systems.[4,7] Inspired by this shortcoming,
as well as a surprising inability to access the targeted key fragment en route to the synthesis
of dictyostatin (1) (Scheme 1), vide infra, ongoing efforts in our lab have focused on the
exploration of phosphate-tether reactivity profiles across a spectrum of substrates. We herein
report the preliminary results of a detailed study highlighting the stereochemical factors
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involved in phosphate tether-mediated diastereotopic differentiation of 1,3-anti-diol subunits
(Figure 1).
Recent efforts towards synthesis of 1,3-anti-diol containing natural products utilizing
phosphate tether-mediated selective reactions[5,6] led to application for dictyostatin, a
marine macrolide with promising antitumor and anticancer activities.[8] Retrosynthetic
analysis of fragments 2 or 3 (Scheme 1) revealed that 1 could, in theory, be constructed via a
phosphate tether-mediated tripodal coupling of POCl3, C2-symmetric diene diol (S,S)-7 and
olefin partner 6, followed by RCM to yield the bicyclo[5.3.1]- and [7.3.1]-phosphates 4 and
5, respectively.
Results and Discussion
Initial studies focused on synthesis of the C1–C8 fragment of dictyostatin via formation of
the Z-configured, bicyclo[5.3.1]-phosphate 4 from triene 9 [via monochlorophosphate
(S,S)-8] (Scheme 2). However, the desired product 4 was not observed.[9] Interestingly,
coupling of (R,R)-8 with 6 generated triene 10, which upon RCM yielded bicyclic phosphate
11 (dictyostatin diastereomeric subunit) in 65%. This result demonstrated that unforeseen
factors were operative, which prompted efforts to carry out a detailed investigation of more
complex tethers.
Studies were next focused on the synthesis of the Z-configured 10-membered subunit 5
(Scheme 1) via RCM with substrates bearing requisite “dictyostatin-like” olefin tether
partners (Scheme 3). In this study, trienes 13a–c, possessing various substitutions at the C3
carbinol (P1 = H, TBS, and MOM), were synthesized. Subsequent RCM of 13a–c afforded
excellent yields of E-configured bicyclo[7.3.1]phosphates 14a–c. In addition, the
diastereomeric triene 15 [derived from (R,R)-8] also produced the RCM product 16 in good
yield and with E-selectivity. Collectively, these results prompted us to carry out detailed
RCM studies to various bicyclo[n.3.1]phosphates.
Investigations began with RCM studies of trienes 18 and 20 constructed from enantiomeric
(S,S)-8 and (R,R)-8 en route to 7-membered bicyclo[4.3.1]phosphates trans-19 and cis-21,
respectively (Scheme 4). In contrast to the elegant diastereoselective RCM studies by Evans
and coworkers7 using Si-tethered dienes where only cis-substituted 7-membered products
were observed, RCM of phosphate trienes 18 and 20, yielded both 7-membered products
trans-19 and cis-21, albeit with different reaction rates and catalyst loadings (Scheme 4). In
addition, the cis-diastereomer reacted at a much faster rate and with better yields.
Presumably, a detrimental 1,2-steric interaction between the CH2OBn group and the
metallocyclobutane in intermediate trans-A outlined in Scheme 4 is operative, thus slowing
RCM for the trans-substituted case.
In order to ascertain additional information regarding the aforementioned 1,2-interaction, a
double diastereotopic differentiation investigation of triene 22 was initiated using RCM.
RCM of triene 22 [derived from the coupling of monochlorophosphate (S,S)-8 with 2,4-
dimethylpenta-1,4-dien-3-ol] exclusively produced the kinetically favored cis-substituted
bicyclo[4.3.1]phosphate 23 via an intermediate lacking a 1,2-interaction as in intermediate
cis-B.
Studies were next directed to the 8-membered RCM reactions of trienes 26 and 30 derived
from the coupling of alcohol (R)-24 (R = H) with monochlorophosphates (S,S)-8 and
(R,R)-8, respectively. Gratifyingly, both 8-membered bicyclo-[5.3.1] phosphates, trans-28
and cis-32, respectively, were formed with good yields (Scheme 6). In similar fashion, the
trienes 27 and 31 were synthesized from methyl-substituted alcohol (R)-25 (R = Me). When
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subjected to the RCM reaction only the trans-29 formed, albeit in only 32% yield, while no
cis-product formation 33 was observed. A plausible explanation for these results is
highlighted with trans-C and cis-D intermediates, whereby the metallocyclobutane would
most likely form on the exo-face presumably due to the concave structure of the bicyclic
phosphate and the size of the Ru-complex. Based on this assumption, in the case of the
formation of cis-33, an unfavorable 1,3-interaction[10] between the vinylic CH3 and
CH2OBn groups impedes RCM. However, for trans-29, no such interaction exists, thus
RCM proceeds, albeit in moderate yield.
Comparative analysis of the non-allylic substituted trienes 26 and 30 that readily underwent
RCM (Scheme 6), to trienes 9 and 10, bearing allylic Me-substitution (Scheme 3), allowed
us to conclude that the stereochemistry of allylic substitution was the deciding factor in the
successful formation of the desired product. Thus, additional studies were conducted for the
RCM reactions of trienes derived from monochlorophosphates (R,R)-8/(S,S)-8 and
substituted homoallyl alcohols syn-34 and anti-35 (Scheme 7). Product formations were
observed only for cis,syn-38 and trans,anti-43, which is consistent with the previously
mentioned preliminary results for dictyostatin, vide supra.
A plausible model was developed in order to provide insight for the observed stereochemical
outcomes seen in the bicyclo[5.3.1]phosphate cases, in which the stereochemistry of allylic
substitution is the critical factor (Figure 2). When considering the metallocyclobutane
intermediates, the previous assumption that metallocyclobutane formation occurs on the
exocyclic face eliminates the intermediates, endo,endo-E and endo,exo-F. Inspection of the
remaining two intermediates, exo,exo-G and exo,endo-H, reveals an unfavorable steric
interaction between the exo-Me and the required exo-metallocyclobutane in the case of
exo,exo-G, which impedes the formation of the resultant bicyclic phosphate. Thus, only
when the allylic Me is endo and the formed metallocyclobutane is exo is the intermediate
energetically accessible such that the reaction can proceed to completion. This trend analysis
therefore accounts for the selectivity.
For experimental confirmation of the proposed intermediates in Figure 2, we synthesized
triene 45a from (±)-2-methylbut-3-en-1-ol and the monochlorophosphate (S,S)-8 in order to
perform a double diastereotopic differentiation experiment (Scheme 8). Subsequent RCM
reaction exclusively generated bicyclo[5.3.1]phosphate diastereomer 46, which was
confirmed by X-ray crystallography, along with unreacted diastereomeric triene 45b.[11] X-
ray crystallography analysis[12] confirmed the endo orientation of the allylic methyl group in
the bicyclic phosphate 46, thus supporting our proposed favorable intermediate exo,endo-H
shown in Figure 2.
Next, we extended the 8-membered RCM studies to include coupling of the homologated
monochlorophosphates 48, 49, 54 and 55 with allylic alcohol 47 (Scheme 9). Trienes 50 and
56, derived from unsubstituted monochlorophosphates 48 and 54 (R = H), respectively,
participated in the RCM reaction although with poor yield for the trans-substituted
bicyclo[5.3.1]phosphate 52 compared to the cis-substituted bicyclo[5.3.1]phosphate 58. The
lowered yield of trans-52 was presumable due to an unfavorable 1,2-interaction between
metallocyclobutane and –CH2OBn in the intermediate trans-I. In the cases of methyl-
substituted homologated trienes 51 and 57, no cis RCM product 59 was observed due to a
highly unfavorable 1,3-interaction (syn-pentane) between –CH3 and –CH2OBn in
intermediate cis-J.[10]
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In conclusion, we have detailed the phosphate tether-mediated diastereotopic differentiation
of C2-symmetric dienediol subunits via RCM. Experimental outcomes were shown to be
highly dependent upon various parameters, including the concave nature of the bicyclic
phosphate, the stereochemistry within each coupling partner and ring size. Plausible
metallocyclobutane-containing intermediates for RCM reactions to bicyclo[4.3.1]- and
[5.3.1]-phosphates are proposed to rationalize observed experimental outcomes. In addition,
notable trans-products in the bicyclo[4.3.1]phosphate series, as well as exclusive E-
selectivity in the bicyclo[7.3.1]phosphate series, were also observed. Further applications in
the synthesis of polyketide natural products, along with RCM studies towards other




To a solution of alcohol 6 (0.152 g, 0.575 mmol) in THF (2.9 mL), at −40 °C under argon,
was added n-BuLi (2.5 M, 0.551 mmol), dropwise. The mixture was allowed to stir for 5
minutes, at which point a solution of phosphate monochloride (S,S)-8 (0.100 g, 0.479 mmol)
in THF (1 mL) was slowly added to the reaction vessel via cannulation. The mixture stirred
at −40 °C for 2 hours (monitored by TLC) and was quenched with 3 mL of aqueous NH4Cl
(sat.). The biphasic solution was separated, and the aqueous layer was extracted EtOAc (3 ×
5 mL). The combined organic layers were washed with brine, dried (Na2SO4), and
concentrated under reduced pressure. Purification via flash chromatography (silica, 2:1
Hexanes/EtOAc) provided 0.172 g (82% yield) of triene product 9, as a colorless oil.13
Optical Rotation: [α]D = +23.0 (c = 0.1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.28 (d, J =
8.0 Hz, 2H), 6.87 (d, J = 8.1 Hz, 2H), 6.01 (ddd, J = 16.7, 10.8, 5.7 Hz, 1H), 5.96–5.78 (m,
2H), 5.45 (d, J = 17.1 Hz, 1H), 5.38 (d, J = 17.2 Hz, 1H), 5.29 (d, J = 10.6 Hz, 2H), 5.10–
5.02 (m, 3H), 4.97–4.90 (m, 1H), 4.60–4.55 (m, 1H), 4.49 (d, J = 11.5 Hz, 1H), 4.36 (d, J =
11.5 Hz, 1H), 3.81 (s, 3H), 3.41 (dd, J = 9.0, 7.1 Hz, 1H), 3.32 (dd, J = 8.9, 7.1 Hz, 1H),
2.50 (dq, J = 13.8, 6.9 Hz, 1H), 2.18–2.11 (m, 1H), 2.06 (ddd, J = 18.5, 14.0, 6.0 Hz, 2H),
1.07 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 159.0,
140.0, 135.4 (d, JCP = 4.0 Hz), 135.3 (d, JCP = 7.6 Hz), 130.7, 129.4, 117.7, 117.1, 115.6,
113.7, 85.0 (d, JCP = 7.4 Hz), 77.3 (d, J = 6.8 Hz), 75.5 (d, JCP = 6.2 Hz), 72.8 (d, JCP = 6.0
Hz), 72.5, 55.3, 41.2 (d, JCP = 3.5 Hz), 36.1 (d, JCP = 3.9 Hz), 35.2 (d, JCP = 7.3 Hz), 17.5,
11.9; 31P NMR (162 MHz, CDCl3) δ −7.01; FTIR (neat): 2952, 2949, 1615, 1547, 1252,
1234, 1009, 845, 741 cm−1; HRMS: cald. for C23H33O6PNa (M+Na)+ 459.1912; found
459.1902 (TOF MS ES+).
(1R,3S,4S,7R,9R,Z)-3-((S)-1-((4-methoxybenzyl)oxy)propan-2-yl)-4-methyl-9-vinyl-2,10,11-
trioxa-1-phosphabicyclo[5.3.1]undec-5-ene 1-oxide (trans,anti-11)
To a flask containing triene phosphate 10 (0.080 g, 0.183 mmol) in CH2Cl2 (dry, degassed,
26 mL), equipped with an argon inlet and reflux condenser, was added portion wise
(ImesH2)(PCy3)(Cl)2Ru=CHPh (G-II)14 (16 mg, 0.018 mmol, 10 mol%), and the reaction
mixture was heated to reflux. Upon completion (monitored by TLC), the reaction was
cooled to room temperature and concentrated under reduced pressure. Purification via flash
chromatography (silica, 2:1 Hexanes/EtOAc) provided 61 mg (65% yield) of the bicyclic
phosphate 11 as a colorless oil.15 Optical Rotation: [α]D = −7.3 (c = 0.16, CHCl3);1H NMR
(500 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.87 (dddd, J = 17.2,
10.6, 5.4, 2.0 Hz, 1H), 5.49 (ddd, J = 11.6, 8.2, 2.8 Hz, 1H), 5.43 (ddd, J = 17.2, 1.2, 1.2 Hz,
1H), 5.39 (d, J = 11.9 Hz, 1H), 5.27 (ddd, J = 10.6, 1.2, 1.1 Hz, 1H), 4.98 (dd, J = 11.8, 5.4
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Hz, 1H), 4.48 (s, 2H), 4.06 (ddd, J = 29.1, 11.5, 3.3 Hz, 1H), 3.80 (s, 3H), 3.71 (t, J = 8.9
Hz, 1H), 3.53–3.45 (m, 1H), 3.48 (dd, J = 9.1, 5.9 Hz, 2H), 2.24–2.11 (m, 2H), 1.78 (ddd, J
= 14.5, 3.9, 1.8 Hz, 1H), 1.19 (d, J = 7.2 Hz, 3H), 1.01 (d, J = 6.6 Hz, 3H); 13C NMR (126
MHz, CDCl3) δ 159.1, 136.0, 135.4 (d, JCP = 10.5 Hz), 130.7, 129.2, 128.1, 117.1 (d, JCP =
1.3 Hz), 113.7, 83.6 (d, JCP = 7.4 Hz), 77.8 (d, JCP = 7.2 Hz), 76.1 (d, JCP = 6.3 Hz), 72.9,
72.2, 55.2, 36.5 (d, JCP = 6.2 Hz), 35.1, 32.6 (d, JCP = 1.3 Hz), 17.4, 9.4; 31P NMR (162
MHz, CDCl3) δ −10.71; FTIR (neat): 2982, 2934, 1605, 1507, 1268, 1241, 1003, 831, 741
cm−1; HRMS: cald. for C21H29O6PNa (M+Na)+ 431.1599; found 431.1575 (TOF MS ES+).
For all other experimental data and spectra, see supporting information.
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Proposed transition states and accessible products.
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Proposed retrosynthesis of dictyostatin via a phosphate tether-mediated desymmetrization
approach.
Chegondi et al. Page 9














RCM to bicyclo[5.3.1]phosphate intermediates en route to key fragments of dictyostatin.
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RCM to bicyclo[7.3.1]phosphate intermediates en route to key fragments of dictyostatin.
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Kinetic control to bicyclo[4.3.1]phosphate.
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Effect of methyl substitution in RCM to bicyclo[5.3.1]phosphates.
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Experimental confirmation for above proposed intermediate exo,endo-H.
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RCM to bicyclo[5.3.1]phosphates with homologated 1,3-anti-dienediol.
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